AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Immunotherapies like checkpoint inhibitors and CAR T cell therapies are transforming cancer care. Clinical labs are on the forefront of deploying currently available tests that help determine which immunotherapies patients should receive, and help monitor their treatment response.

Ask the Expert

Clinical labs should calibrate their pipettes before putting them into service, and calibrate and perform preventive maintenance on them periodically thereafter. Vendors calibrate pipettes before shipping them to laboratories, providing documentation at that time about a pipette’s bias and imprecision, as well as the method used to calibrate it.

Bench Matters

Federal Insider

AACC is criticizing state Medicaid agencies that are reducing their payment rates for clinical laboratory testing even further than the recent cuts to the Medicare clinical laboratory fee schedule implemented under PAMA.

Focus on Mass Spectrometry

Now that 29 states have passed medical marijuana laws and nine have legalized cannabis for recreational use, there is growing concern about the potential for more impaired drivers on the road. Al-ready states that have legalized cannabis have experienced more traffic accidents and fatalities with cannabis detected.

Industry Playbook

Mini Review

Regulatory Roundup

Special Supplement

Several sessions at the 70th AACC Annual Scientific Meeting will explore how laboratories of the future will be able to demonstrate value in healthcare systems and use emerging technology to reduce pre- and postanalytical errors.

The Sample